Arcadia BiosciencesRKDA
13F holders, Q1 2025 (March 31)14holders +1
2new positions
1sold out
$2.90avg. 13F price*
At the end of Q1 2025, 14 institutions reported holding Arcadia Biosciences Inc. (RKDA) in their 13F filings, up 1 from Q4 2024. 2 opened new positions and 1 sold out. The largest holders were Mariner, LLC ($82K), Vanguard Group Inc. ($40K) and Geode Capital Management, LLC ($36K).
- Company
- Arcadia Biosciences Inc.
- CUSIP
- 039014303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1K |
| Exits | 1 | $444 |
All 13F filers, Q4 2024 → Q1 2025: 3,418 shares bought and 5,460 shares sold, net −2,042 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Mariner, LLC | 0.00% | Add +9.9% | 27,481 | $82K |
| Vanguard Group Inc. | 0.00% | No change | 14,038 | $40K |
| Geode Capital Management, LLC | 0.00% | Add +4.0% | 12,795 | $36K |
| State Street Corp. | 0.00% | No change | 12,146 | $34K |
| UBS Group AG | 0.00% | Reduce -38.6% | 8,560 | $25K |
| Morgan Stanley | 0.00% | Add +0.2% | 608 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 437 | $1K |
| Atticus Wealth Management, LLC | 0.00% | No change | 272 | $808 |
| SBI Securities Co., Ltd. | 0.00% | No change | 120 | $356 |
| Group One Trading LLC | 0.00% | No change | 18 | $51 |
| Bank of America Corp. | 0.00% | No change | 11 | $33 |
| Assetmark, Inc. | 0.00% | No change | 5 | $15 |
| Harbour Investments, Inc. | 0.00% | No change | 1 | $3 |
| Larson Financial Group LLC | 0.00% | New | 1 | $3 |
"% of holder's portfolio" is RKDA's weight in each manager's 13F, not the share of Arcadia Biosciences Inc. the manager owns.